A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC–IV (AGO-OVAR protocol OVAR-8)

This publication has 23 references indexed in Scilit:

• Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer
  Gynecologic Oncology, 2004
• Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study
  Gynecologic Oncology, 2004
• Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
  Journal of Clinical Oncology, 2003
• Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
  JNCI: Journal of the National Cancer Institute, 2000
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer Patients
  JNCI: Journal of the National Cancer Institute, 1994
• Comparison of the Emetogenic Potential Between Cisplatin and Carboplatin in Combination with Alkylating Agents
  Acta Oncologica, 1994
• A Comparison of the Toxicity and Efficacy of Cisplatin and Carboplatin in Advanced Ovarian Cancer
  Acta Oncologica, 1989
• Promotion of microtubule assembly in vitro by taxol
  Nature, 1979
• Creatinine Clearance: Bedside Estimate
  Annals of Internal Medicine, 1973